GRAP


Summary: This gene encodes a member of the GRB2/Sem5/Drk family and functions as a cytoplasmic signaling protein which contains an SH2 domain flanked by two SH3 domains. The SH2 domain interacts with ligand-activated receptors for stem cell factor and erythropoietin, and facilitates the formation of a stable complex with the BCR-ABL oncoprotein. This protein also associates with the Ras guanine nucleotide exchange factor SOS1 (son of sevenless homolog 1) through its N-terminal SH3 domain. In general, it couples signals from receptor and cytoplasmic tyrosine kinases to the Ras signaling pathway. [provided by RefSeq, Jul 2012].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

KINASETYROSINE KINASE

GO terms in GRAP


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC TAS GO:0005737 cytoplasm
CC TAS GO:0005829 cytosol
BP TAS GO:0007265 Ras protein signal transduction
BP TAS GO:0007267 cell-cell signaling
BP IEA GO:0009967 positive regulation of signal transduction
MF TAS GO:0005070 SH3/SH2 adaptor activity
Showing 1 to 6 of 7 rows

Gene expression in normal tissue: GRAP

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

ERK MAPK signaling1

Pathways in GRAP


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1433557 Signaling by SCF-KIT
reactome R-HSA-162582 Signal Transduction
reactome R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
netpath Pathway_KitReceptor KitReceptor
netpath Pathway_TCR TCR
Showing 1 to 5 of 5 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in GRAP

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​